nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—FKBP1A—esophageal cancer	0.244	0.462	CbGaD
Cyclosporine—SLC10A2—esophageal cancer	0.218	0.412	CbGaD
Cyclosporine—ABCC2—esophageal cancer	0.0489	0.0924	CbGaD
Cyclosporine—ABCC10—Methotrexate—esophageal cancer	0.039	0.145	CbGbCtD
Cyclosporine—ABCC3—Cisplatin—esophageal cancer	0.0378	0.14	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—esophageal cancer	0.0245	0.0911	CbGbCtD
Cyclosporine—ABCC2—Carboplatin—esophageal cancer	0.0201	0.0746	CbGbCtD
Cyclosporine—ABCG2—Carboplatin—esophageal cancer	0.0182	0.0675	CbGbCtD
Cyclosporine—ABCB1—esophageal cancer	0.018	0.034	CbGaD
Cyclosporine—ABCC2—Cisplatin—esophageal cancer	0.0172	0.0638	CbGbCtD
Cyclosporine—ABCG2—Cisplatin—esophageal cancer	0.0155	0.0576	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—esophageal cancer	0.0151	0.0559	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—esophageal cancer	0.0134	0.0499	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—esophageal cancer	0.0127	0.0471	CbGbCtD
Cyclosporine—CYP2C9—Capecitabine—esophageal cancer	0.0115	0.0425	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—esophageal cancer	0.0111	0.0414	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—esophageal cancer	0.0101	0.0374	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—esophageal cancer	0.00816	0.0303	CbGbCtD
Cyclosporine—CYP2C9—Cisplatin—esophageal cancer	0.00577	0.0214	CbGbCtD
Cyclosporine—ABCB1—Cisplatin—esophageal cancer	0.0056	0.0208	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—esophageal cancer	0.00363	0.0135	CbGbCtD
Cyclosporine—PPIB—exocrine gland—esophageal cancer	0.00189	0.0433	CbGeAlD
Cyclosporine—FKBP1B—lung—esophageal cancer	0.00124	0.0283	CbGeAlD
Cyclosporine—PPIB—neck—esophageal cancer	0.00121	0.0277	CbGeAlD
Cyclosporine—PPID—bronchus—esophageal cancer	0.00117	0.0268	CbGeAlD
Cyclosporine—CAMLG—bronchus—esophageal cancer	0.00115	0.0264	CbGeAlD
Cyclosporine—PPID—smooth muscle tissue—esophageal cancer	0.00115	0.0262	CbGeAlD
Cyclosporine—PPID—trachea—esophageal cancer	0.00105	0.024	CbGeAlD
Cyclosporine—PPIA—bronchus—esophageal cancer	0.00105	0.024	CbGeAlD
Cyclosporine—CAMLG—trachea—esophageal cancer	0.00104	0.0237	CbGeAlD
Cyclosporine—SLC10A2—digestive system—esophageal cancer	0.00099	0.0226	CbGeAlD
Cyclosporine—FKBP4—digestive system—esophageal cancer	0.000981	0.0224	CbGeAlD
Cyclosporine—PPIA—trachea—esophageal cancer	0.000945	0.0216	CbGeAlD
Cyclosporine—PPIF—bronchus—esophageal cancer	0.000852	0.0195	CbGeAlD
Cyclosporine—FKBP1B—lymph node—esophageal cancer	0.000847	0.0194	CbGeAlD
Cyclosporine—PPIF—smooth muscle tissue—esophageal cancer	0.000833	0.0191	CbGeAlD
Cyclosporine—PPIB—epithelium—esophageal cancer	0.000823	0.0188	CbGeAlD
Cyclosporine—FKBP4—lung—esophageal cancer	0.000819	0.0187	CbGeAlD
Cyclosporine—PPP3CA—bronchus—esophageal cancer	0.000816	0.0186	CbGeAlD
Cyclosporine—PPIB—bronchus—esophageal cancer	0.000811	0.0185	CbGeAlD
Cyclosporine—FKBP1A—neck—esophageal cancer	0.000809	0.0185	CbGeAlD
Cyclosporine—PPP3CA—smooth muscle tissue—esophageal cancer	0.000798	0.0182	CbGeAlD
Cyclosporine—PPIB—smooth muscle tissue—esophageal cancer	0.000793	0.0181	CbGeAlD
Cyclosporine—PPIF—trachea—esophageal cancer	0.000765	0.0175	CbGeAlD
Cyclosporine—PPID—lung—esophageal cancer	0.000756	0.0173	CbGeAlD
Cyclosporine—CAMLG—lung—esophageal cancer	0.000745	0.017	CbGeAlD
Cyclosporine—PPP3CA—trachea—esophageal cancer	0.000732	0.0167	CbGeAlD
Cyclosporine—PPIB—trachea—esophageal cancer	0.000728	0.0166	CbGeAlD
Cyclosporine—PPIA—lung—esophageal cancer	0.000679	0.0155	CbGeAlD
Cyclosporine—PPIF—digestive system—esophageal cancer	0.000658	0.015	CbGeAlD
Cyclosporine—PPP3CA—digestive system—esophageal cancer	0.00063	0.0144	CbGeAlD
Cyclosporine—PPIB—digestive system—esophageal cancer	0.000626	0.0143	CbGeAlD
Cyclosporine—FKBP4—lymph node—esophageal cancer	0.00056	0.0128	CbGeAlD
Cyclosporine—FKBP1A—epithelium—esophageal cancer	0.00055	0.0126	CbGeAlD
Cyclosporine—PPIF—lung—esophageal cancer	0.00055	0.0126	CbGeAlD
Cyclosporine—FKBP1A—bronchus—esophageal cancer	0.000542	0.0124	CbGeAlD
Cyclosporine—SLC10A1—digestive system—esophageal cancer	0.000536	0.0122	CbGeAlD
Cyclosporine—FKBP1A—smooth muscle tissue—esophageal cancer	0.00053	0.0121	CbGeAlD
Cyclosporine—ABCB11—digestive system—esophageal cancer	0.00053	0.0121	CbGeAlD
Cyclosporine—PPP3CA—lung—esophageal cancer	0.000526	0.012	CbGeAlD
Cyclosporine—PPIB—lung—esophageal cancer	0.000523	0.012	CbGeAlD
Cyclosporine—PPID—lymph node—esophageal cancer	0.000517	0.0118	CbGeAlD
Cyclosporine—CAMLG—lymph node—esophageal cancer	0.00051	0.0116	CbGeAlD
Cyclosporine—FKBP1A—trachea—esophageal cancer	0.000487	0.0111	CbGeAlD
Cyclosporine—PPIA—lymph node—esophageal cancer	0.000464	0.0106	CbGeAlD
Cyclosporine—ABCC10—bronchus—esophageal cancer	0.000434	0.00992	CbGeAlD
Cyclosporine—FKBP1A—digestive system—esophageal cancer	0.000419	0.00957	CbGeAlD
Cyclosporine—ABCC10—trachea—esophageal cancer	0.00039	0.00891	CbGeAlD
Cyclosporine—PPIF—lymph node—esophageal cancer	0.000376	0.00859	CbGeAlD
Cyclosporine—PPP3CA—lymph node—esophageal cancer	0.00036	0.00823	CbGeAlD
Cyclosporine—PPIB—lymph node—esophageal cancer	0.000358	0.00818	CbGeAlD
Cyclosporine—SLCO1B1—digestive system—esophageal cancer	0.000355	0.00812	CbGeAlD
Cyclosporine—FKBP1A—lung—esophageal cancer	0.00035	0.00799	CbGeAlD
Cyclosporine—ABCC3—digestive system—esophageal cancer	0.000337	0.0077	CbGeAlD
Cyclosporine—ABCC10—digestive system—esophageal cancer	0.000335	0.00767	CbGeAlD
Cyclosporine—ABCC1—bronchus—esophageal cancer	0.000307	0.00702	CbGeAlD
Cyclosporine—SLCO1A2—digestive system—esophageal cancer	0.000289	0.00661	CbGeAlD
Cyclosporine—ABCC3—lung—esophageal cancer	0.000281	0.00643	CbGeAlD
Cyclosporine—ABCC10—lung—esophageal cancer	0.00028	0.0064	CbGeAlD
Cyclosporine—ABCC1—trachea—esophageal cancer	0.000276	0.0063	CbGeAlD
Cyclosporine—ABCC2—digestive system—esophageal cancer	0.000269	0.00615	CbGeAlD
Cyclosporine—SLCO1A2—lung—esophageal cancer	0.000241	0.00552	CbGeAlD
Cyclosporine—FKBP1A—lymph node—esophageal cancer	0.000239	0.00547	CbGeAlD
Cyclosporine—CYP2C19—digestive system—esophageal cancer	0.000231	0.00529	CbGeAlD
Cyclosporine—ABCC1—lung—esophageal cancer	0.000198	0.00453	CbGeAlD
Cyclosporine—ABCC3—lymph node—esophageal cancer	0.000193	0.0044	CbGeAlD
Cyclosporine—ABCC10—lymph node—esophageal cancer	0.000192	0.00438	CbGeAlD
Cyclosporine—CYP3A5—digestive system—esophageal cancer	0.000182	0.00417	CbGeAlD
Cyclosporine—CYP2C9—digestive system—esophageal cancer	0.000179	0.0041	CbGeAlD
Cyclosporine—ABCG2—lung—esophageal cancer	0.000164	0.00375	CbGeAlD
Cyclosporine—ABCC2—lymph node—esophageal cancer	0.000154	0.00352	CbGeAlD
Cyclosporine—CYP3A5—lung—esophageal cancer	0.000152	0.00348	CbGeAlD
Cyclosporine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000151	0.00219	CcSEcCtD
Cyclosporine—Myocardial infarction—Cisplatin—esophageal cancer	0.000151	0.00219	CcSEcCtD
Cyclosporine—Cardiac failure—Capecitabine—esophageal cancer	0.000151	0.00219	CcSEcCtD
Cyclosporine—Lethargy—Capecitabine—esophageal cancer	0.00015	0.00218	CcSEcCtD
Cyclosporine—Stomatitis—Cisplatin—esophageal cancer	0.00015	0.00217	CcSEcCtD
Cyclosporine—Conjunctivitis—Cisplatin—esophageal cancer	0.000149	0.00217	CcSEcCtD
Cyclosporine—Osteoarthritis—Capecitabine—esophageal cancer	0.000147	0.00213	CcSEcCtD
Cyclosporine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000146	0.00212	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000145	0.00211	CcSEcCtD
Cyclosporine—Migraine—Capecitabine—esophageal cancer	0.000145	0.0021	CcSEcCtD
Cyclosporine—Mood swings—Capecitabine—esophageal cancer	0.000139	0.00202	CcSEcCtD
Cyclosporine—Coma—Methotrexate—esophageal cancer	0.000138	0.002	CcSEcCtD
Cyclosporine—Blood creatinine increased—Capecitabine—esophageal cancer	0.000138	0.002	CcSEcCtD
Cyclosporine—CYP3A4—digestive system—esophageal cancer	0.000137	0.00313	CbGeAlD
Cyclosporine—Neoplasm—Methotrexate—esophageal cancer	0.000136	0.00198	CcSEcCtD
Cyclosporine—Urine output increased—Methotrexate—esophageal cancer	0.000136	0.00198	CcSEcCtD
Cyclosporine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000136	0.00198	CcSEcCtD
Cyclosporine—Connective tissue disorder—Cisplatin—esophageal cancer	0.000136	0.00197	CcSEcCtD
Cyclosporine—ABCC1—lymph node—esophageal cancer	0.000135	0.0031	CbGeAlD
Cyclosporine—Urethral disorder—Cisplatin—esophageal cancer	0.000135	0.00196	CcSEcCtD
Cyclosporine—Gynaecomastia—Methotrexate—esophageal cancer	0.000135	0.00196	CcSEcCtD
Cyclosporine—Dry skin—Capecitabine—esophageal cancer	0.000135	0.00196	CcSEcCtD
Cyclosporine—CYP2D6—digestive system—esophageal cancer	0.000135	0.00308	CbGeAlD
Cyclosporine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000134	0.00195	CcSEcCtD
Cyclosporine—Visual impairment—Cisplatin—esophageal cancer	0.000133	0.00193	CcSEcCtD
Cyclosporine—Breast disorder—Capecitabine—esophageal cancer	0.000133	0.00193	CcSEcCtD
Cyclosporine—Sepsis—Methotrexate—esophageal cancer	0.000131	0.0019	CcSEcCtD
Cyclosporine—Gastritis—Capecitabine—esophageal cancer	0.00013	0.00189	CcSEcCtD
Cyclosporine—Muscular weakness—Capecitabine—esophageal cancer	0.00013	0.00188	CcSEcCtD
Cyclosporine—Tinnitus—Cisplatin—esophageal cancer	0.000129	0.00187	CcSEcCtD
Cyclosporine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000128	0.00186	CcSEcCtD
Cyclosporine—Flushing—Cisplatin—esophageal cancer	0.000128	0.00186	CcSEcCtD
Cyclosporine—Abdominal distension—Capecitabine—esophageal cancer	0.000128	0.00186	CcSEcCtD
Cyclosporine—ABCB1—epithelium—esophageal cancer	0.000127	0.00291	CbGeAlD
Cyclosporine—Dysphagia—Capecitabine—esophageal cancer	0.000127	0.00184	CcSEcCtD
Cyclosporine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000126	0.00183	CcSEcCtD
Cyclosporine—Bronchospasm—Capecitabine—esophageal cancer	0.000125	0.00181	CcSEcCtD
Cyclosporine—Polyuria—Methotrexate—esophageal cancer	0.000125	0.00181	CcSEcCtD
Cyclosporine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000124	0.0018	CcSEcCtD
Cyclosporine—Sweating increased—Capecitabine—esophageal cancer	0.000124	0.0018	CcSEcCtD
Cyclosporine—Arrhythmia—Cisplatin—esophageal cancer	0.000123	0.00179	CcSEcCtD
Cyclosporine—Bronchitis—Capecitabine—esophageal cancer	0.000122	0.00177	CcSEcCtD
Cyclosporine—Alopecia—Cisplatin—esophageal cancer	0.000122	0.00177	CcSEcCtD
Cyclosporine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000122	0.00177	CcSEcCtD
Cyclosporine—Hepatic failure—Methotrexate—esophageal cancer	0.000122	0.00177	CcSEcCtD
Cyclosporine—Malnutrition—Cisplatin—esophageal cancer	0.00012	0.00174	CcSEcCtD
Cyclosporine—Dysuria—Capecitabine—esophageal cancer	0.000119	0.00172	CcSEcCtD
Cyclosporine—Flatulence—Cisplatin—esophageal cancer	0.000118	0.00172	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000118	0.00171	CcSEcCtD
Cyclosporine—Weight increased—Capecitabine—esophageal cancer	0.000116	0.00168	CcSEcCtD
Cyclosporine—Visual disturbance—Methotrexate—esophageal cancer	0.000116	0.00168	CcSEcCtD
Cyclosporine—Muscle spasms—Cisplatin—esophageal cancer	0.000116	0.00168	CcSEcCtD
Cyclosporine—Weight decreased—Capecitabine—esophageal cancer	0.000115	0.00167	CcSEcCtD
Cyclosporine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000115	0.00166	CcSEcCtD
Cyclosporine—Pneumonia—Capecitabine—esophageal cancer	0.000114	0.00165	CcSEcCtD
Cyclosporine—Infestation—Capecitabine—esophageal cancer	0.000113	0.00164	CcSEcCtD
Cyclosporine—Infestation NOS—Capecitabine—esophageal cancer	0.000113	0.00164	CcSEcCtD
Cyclosporine—Vision blurred—Cisplatin—esophageal cancer	0.000113	0.00164	CcSEcCtD
Cyclosporine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000113	0.00164	CcSEcCtD
Cyclosporine—Depression—Capecitabine—esophageal cancer	0.000113	0.00164	CcSEcCtD
Cyclosporine—Tremor—Cisplatin—esophageal cancer	0.000113	0.00163	CcSEcCtD
Cyclosporine—ABCB1—trachea—esophageal cancer	0.000113	0.00257	CbGeAlD
Cyclosporine—ABCG2—lymph node—esophageal cancer	0.000112	0.00256	CbGeAlD
Cyclosporine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000112	0.00162	CcSEcCtD
Cyclosporine—Lethargy—Methotrexate—esophageal cancer	0.000112	0.00162	CcSEcCtD
Cyclosporine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000111	0.00162	CcSEcCtD
Cyclosporine—Renal failure—Capecitabine—esophageal cancer	0.000111	0.00162	CcSEcCtD
Cyclosporine—Myocardial infarction—Capecitabine—esophageal cancer	0.000111	0.00161	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000111	0.00161	CcSEcCtD
Cyclosporine—Anaemia—Cisplatin—esophageal cancer	0.000111	0.00161	CcSEcCtD
Cyclosporine—Stomatitis—Capecitabine—esophageal cancer	0.00011	0.0016	CcSEcCtD
Cyclosporine—Jaundice—Capecitabine—esophageal cancer	0.00011	0.0016	CcSEcCtD
Cyclosporine—Conjunctivitis—Capecitabine—esophageal cancer	0.00011	0.0016	CcSEcCtD
Cyclosporine—Urinary tract infection—Capecitabine—esophageal cancer	0.00011	0.0016	CcSEcCtD
Cyclosporine—Osteoarthritis—Methotrexate—esophageal cancer	0.000109	0.00159	CcSEcCtD
Cyclosporine—Malaise—Cisplatin—esophageal cancer	0.000108	0.00157	CcSEcCtD
Cyclosporine—Haematuria—Capecitabine—esophageal cancer	0.000108	0.00157	CcSEcCtD
Cyclosporine—Leukopenia—Cisplatin—esophageal cancer	0.000108	0.00156	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000107	0.00156	CcSEcCtD
Cyclosporine—Epistaxis—Capecitabine—esophageal cancer	0.000107	0.00155	CcSEcCtD
Cyclosporine—Convulsion—Cisplatin—esophageal cancer	0.000104	0.00151	CcSEcCtD
Cyclosporine—Mood swings—Methotrexate—esophageal cancer	0.000104	0.0015	CcSEcCtD
Cyclosporine—Myalgia—Cisplatin—esophageal cancer	0.000102	0.00148	CcSEcCtD
Cyclosporine—Haemoglobin—Capecitabine—esophageal cancer	0.000102	0.00148	CcSEcCtD
Cyclosporine—Rhinitis—Capecitabine—esophageal cancer	0.000102	0.00148	CcSEcCtD
Cyclosporine—Anxiety—Cisplatin—esophageal cancer	0.000102	0.00148	CcSEcCtD
Cyclosporine—Haemorrhage—Capecitabine—esophageal cancer	0.000102	0.00148	CcSEcCtD
Cyclosporine—Hepatitis—Capecitabine—esophageal cancer	0.000102	0.00148	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000102	0.00147	CcSEcCtD
Cyclosporine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000101	0.00147	CcSEcCtD
Cyclosporine—Discomfort—Cisplatin—esophageal cancer	0.000101	0.00147	CcSEcCtD
Cyclosporine—Pharyngitis—Capecitabine—esophageal cancer	0.000101	0.00146	CcSEcCtD
Cyclosporine—Urinary tract disorder—Capecitabine—esophageal cancer	0.0001	0.00146	CcSEcCtD
Cyclosporine—Connective tissue disorder—Capecitabine—esophageal cancer	0.0001	0.00145	CcSEcCtD
Cyclosporine—Urethral disorder—Capecitabine—esophageal cancer	9.97e-05	0.00145	CcSEcCtD
Cyclosporine—Breast disorder—Methotrexate—esophageal cancer	9.89e-05	0.00144	CcSEcCtD
Cyclosporine—Oedema—Cisplatin—esophageal cancer	9.81e-05	0.00142	CcSEcCtD
Cyclosporine—Anaphylactic shock—Cisplatin—esophageal cancer	9.81e-05	0.00142	CcSEcCtD
Cyclosporine—Visual impairment—Capecitabine—esophageal cancer	9.81e-05	0.00142	CcSEcCtD
Cyclosporine—Infection—Cisplatin—esophageal cancer	9.74e-05	0.00141	CcSEcCtD
Cyclosporine—ABCB1—digestive system—esophageal cancer	9.68e-05	0.00221	CbGeAlD
Cyclosporine—Nervous system disorder—Cisplatin—esophageal cancer	9.62e-05	0.0014	CcSEcCtD
Cyclosporine—Thrombocytopenia—Cisplatin—esophageal cancer	9.6e-05	0.00139	CcSEcCtD
Cyclosporine—Skin disorder—Cisplatin—esophageal cancer	9.53e-05	0.00138	CcSEcCtD
Cyclosporine—Tinnitus—Capecitabine—esophageal cancer	9.49e-05	0.00138	CcSEcCtD
Cyclosporine—Hyperhidrosis—Cisplatin—esophageal cancer	9.48e-05	0.00138	CcSEcCtD
Cyclosporine—Flushing—Capecitabine—esophageal cancer	9.44e-05	0.00137	CcSEcCtD
Cyclosporine—Anorexia—Cisplatin—esophageal cancer	9.35e-05	0.00136	CcSEcCtD
Cyclosporine—Pancreatitis—Methotrexate—esophageal cancer	9.28e-05	0.00135	CcSEcCtD
Cyclosporine—Angiopathy—Capecitabine—esophageal cancer	9.23e-05	0.00134	CcSEcCtD
Cyclosporine—Mediastinal disorder—Capecitabine—esophageal cancer	9.17e-05	0.00133	CcSEcCtD
Cyclosporine—Chills—Capecitabine—esophageal cancer	9.13e-05	0.00132	CcSEcCtD
Cyclosporine—Arrhythmia—Capecitabine—esophageal cancer	9.09e-05	0.00132	CcSEcCtD
Cyclosporine—Abdominal discomfort—Methotrexate—esophageal cancer	9.07e-05	0.00132	CcSEcCtD
Cyclosporine—Alopecia—Capecitabine—esophageal cancer	8.99e-05	0.0013	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	8.94e-05	0.0013	CcSEcCtD
Cyclosporine—Mental disorder—Capecitabine—esophageal cancer	8.91e-05	0.00129	CcSEcCtD
Cyclosporine—Malnutrition—Capecitabine—esophageal cancer	8.86e-05	0.00128	CcSEcCtD
Cyclosporine—Dysuria—Methotrexate—esophageal cancer	8.85e-05	0.00128	CcSEcCtD
Cyclosporine—Paraesthesia—Cisplatin—esophageal cancer	8.81e-05	0.00128	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Methotrexate—esophageal cancer	8.8e-05	0.00128	CcSEcCtD
Cyclosporine—Dyspnoea—Cisplatin—esophageal cancer	8.74e-05	0.00127	CcSEcCtD
Cyclosporine—Flatulence—Capecitabine—esophageal cancer	8.73e-05	0.00127	CcSEcCtD
Cyclosporine—Dysgeusia—Capecitabine—esophageal cancer	8.67e-05	0.00126	CcSEcCtD
Cyclosporine—Decreased appetite—Cisplatin—esophageal cancer	8.53e-05	0.00124	CcSEcCtD
Cyclosporine—Muscle spasms—Capecitabine—esophageal cancer	8.52e-05	0.00124	CcSEcCtD
Cyclosporine—Pneumonia—Methotrexate—esophageal cancer	8.49e-05	0.00123	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Cisplatin—esophageal cancer	8.47e-05	0.00123	CcSEcCtD
Cyclosporine—Infestation—Methotrexate—esophageal cancer	8.44e-05	0.00122	CcSEcCtD
Cyclosporine—Infestation NOS—Methotrexate—esophageal cancer	8.44e-05	0.00122	CcSEcCtD
Cyclosporine—Depression—Methotrexate—esophageal cancer	8.41e-05	0.00122	CcSEcCtD
Cyclosporine—Pain—Cisplatin—esophageal cancer	8.39e-05	0.00122	CcSEcCtD
Cyclosporine—Vision blurred—Capecitabine—esophageal cancer	8.35e-05	0.00121	CcSEcCtD
Cyclosporine—Tremor—Capecitabine—esophageal cancer	8.3e-05	0.0012	CcSEcCtD
Cyclosporine—Renal failure—Methotrexate—esophageal cancer	8.29e-05	0.0012	CcSEcCtD
Cyclosporine—Stomatitis—Methotrexate—esophageal cancer	8.23e-05	0.00119	CcSEcCtD
Cyclosporine—Ill-defined disorder—Capecitabine—esophageal cancer	8.22e-05	0.00119	CcSEcCtD
Cyclosporine—Conjunctivitis—Methotrexate—esophageal cancer	8.2e-05	0.00119	CcSEcCtD
Cyclosporine—Anaemia—Capecitabine—esophageal cancer	8.19e-05	0.00119	CcSEcCtD
Cyclosporine—ABCB1—lung—esophageal cancer	8.09e-05	0.00185	CbGeAlD
Cyclosporine—Feeling abnormal—Cisplatin—esophageal cancer	8.08e-05	0.00117	CcSEcCtD
Cyclosporine—Haematuria—Methotrexate—esophageal cancer	8.05e-05	0.00117	CcSEcCtD
Cyclosporine—Malaise—Capecitabine—esophageal cancer	7.99e-05	0.00116	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Methotrexate—esophageal cancer	7.98e-05	0.00116	CcSEcCtD
Cyclosporine—Epistaxis—Methotrexate—esophageal cancer	7.96e-05	0.00115	CcSEcCtD
Cyclosporine—Vertigo—Capecitabine—esophageal cancer	7.96e-05	0.00115	CcSEcCtD
Cyclosporine—Leukopenia—Capecitabine—esophageal cancer	7.93e-05	0.00115	CcSEcCtD
Cyclosporine—Body temperature increased—Cisplatin—esophageal cancer	7.75e-05	0.00112	CcSEcCtD
Cyclosporine—Cough—Capecitabine—esophageal cancer	7.73e-05	0.00112	CcSEcCtD
Cyclosporine—Hypertension—Capecitabine—esophageal cancer	7.65e-05	0.00111	CcSEcCtD
Cyclosporine—Haemoglobin—Methotrexate—esophageal cancer	7.61e-05	0.0011	CcSEcCtD
Cyclosporine—Haemorrhage—Methotrexate—esophageal cancer	7.58e-05	0.0011	CcSEcCtD
Cyclosporine—Hepatitis—Methotrexate—esophageal cancer	7.58e-05	0.0011	CcSEcCtD
Cyclosporine—Myalgia—Capecitabine—esophageal cancer	7.54e-05	0.00109	CcSEcCtD
Cyclosporine—Chest pain—Capecitabine—esophageal cancer	7.54e-05	0.00109	CcSEcCtD
Cyclosporine—Arthralgia—Capecitabine—esophageal cancer	7.54e-05	0.00109	CcSEcCtD
Cyclosporine—Pharyngitis—Methotrexate—esophageal cancer	7.52e-05	0.00109	CcSEcCtD
Cyclosporine—Anxiety—Capecitabine—esophageal cancer	7.52e-05	0.00109	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	7.49e-05	0.00109	CcSEcCtD
Cyclosporine—Urinary tract disorder—Methotrexate—esophageal cancer	7.48e-05	0.00109	CcSEcCtD
Cyclosporine—Discomfort—Capecitabine—esophageal cancer	7.45e-05	0.00108	CcSEcCtD
Cyclosporine—Urethral disorder—Methotrexate—esophageal cancer	7.43e-05	0.00108	CcSEcCtD
Cyclosporine—Dry mouth—Capecitabine—esophageal cancer	7.38e-05	0.00107	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—esophageal cancer	7.3e-05	0.00106	CcSEcCtD
Cyclosporine—Confusional state—Capecitabine—esophageal cancer	7.29e-05	0.00106	CcSEcCtD
Cyclosporine—Oedema—Capecitabine—esophageal cancer	7.23e-05	0.00105	CcSEcCtD
Cyclosporine—Hypersensitivity—Cisplatin—esophageal cancer	7.23e-05	0.00105	CcSEcCtD
Cyclosporine—Infection—Capecitabine—esophageal cancer	7.18e-05	0.00104	CcSEcCtD
Cyclosporine—Nervous system disorder—Capecitabine—esophageal cancer	7.09e-05	0.00103	CcSEcCtD
Cyclosporine—Thrombocytopenia—Capecitabine—esophageal cancer	7.08e-05	0.00103	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—esophageal cancer	7.06e-05	0.00102	CcSEcCtD
Cyclosporine—Asthenia—Cisplatin—esophageal cancer	7.04e-05	0.00102	CcSEcCtD
Cyclosporine—Skin disorder—Capecitabine—esophageal cancer	7.02e-05	0.00102	CcSEcCtD
Cyclosporine—Hyperhidrosis—Capecitabine—esophageal cancer	6.99e-05	0.00101	CcSEcCtD
Cyclosporine—Anorexia—Capecitabine—esophageal cancer	6.89e-05	0.001	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—esophageal cancer	6.87e-05	0.000997	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—esophageal cancer	6.83e-05	0.00099	CcSEcCtD
Cyclosporine—Chills—Methotrexate—esophageal cancer	6.8e-05	0.000986	CcSEcCtD
Cyclosporine—Diarrhoea—Cisplatin—esophageal cancer	6.71e-05	0.000973	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—esophageal cancer	6.69e-05	0.000971	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—esophageal cancer	6.64e-05	0.000963	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—esophageal cancer	6.59e-05	0.000957	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	6.59e-05	0.000955	CcSEcCtD
Cyclosporine—Insomnia—Capecitabine—esophageal cancer	6.54e-05	0.000948	CcSEcCtD
Cyclosporine—Paraesthesia—Capecitabine—esophageal cancer	6.49e-05	0.000942	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—esophageal cancer	6.46e-05	0.000937	CcSEcCtD
Cyclosporine—Dyspnoea—Capecitabine—esophageal cancer	6.45e-05	0.000935	CcSEcCtD
Cyclosporine—Dyspepsia—Capecitabine—esophageal cancer	6.36e-05	0.000923	CcSEcCtD
Cyclosporine—Decreased appetite—Capecitabine—esophageal cancer	6.28e-05	0.000912	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Capecitabine—esophageal cancer	6.24e-05	0.000905	CcSEcCtD
Cyclosporine—Vomiting—Cisplatin—esophageal cancer	6.24e-05	0.000905	CcSEcCtD
Cyclosporine—Fatigue—Capecitabine—esophageal cancer	6.23e-05	0.000904	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—esophageal cancer	6.21e-05	0.000901	CcSEcCtD
Cyclosporine—Rash—Cisplatin—esophageal cancer	6.18e-05	0.000897	CcSEcCtD
Cyclosporine—Constipation—Capecitabine—esophageal cancer	6.18e-05	0.000897	CcSEcCtD
Cyclosporine—Pain—Capecitabine—esophageal cancer	6.18e-05	0.000897	CcSEcCtD
Cyclosporine—Dermatitis—Cisplatin—esophageal cancer	6.18e-05	0.000896	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—esophageal cancer	6.12e-05	0.000887	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—esophageal cancer	6.09e-05	0.000884	CcSEcCtD
Cyclosporine—Feeling abnormal—Capecitabine—esophageal cancer	5.96e-05	0.000864	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—esophageal cancer	5.95e-05	0.000863	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—esophageal cancer	5.92e-05	0.000859	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Capecitabine—esophageal cancer	5.91e-05	0.000858	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—esophageal cancer	5.9e-05	0.000856	CcSEcCtD
Cyclosporine—Nausea—Cisplatin—esophageal cancer	5.83e-05	0.000845	CcSEcCtD
Cyclosporine—Cough—Methotrexate—esophageal cancer	5.75e-05	0.000835	CcSEcCtD
Cyclosporine—Urticaria—Capecitabine—esophageal cancer	5.74e-05	0.000833	CcSEcCtD
Cyclosporine—Abdominal pain—Capecitabine—esophageal cancer	5.71e-05	0.000829	CcSEcCtD
Cyclosporine—Body temperature increased—Capecitabine—esophageal cancer	5.71e-05	0.000829	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—esophageal cancer	5.71e-05	0.000829	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—esophageal cancer	5.61e-05	0.000814	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—esophageal cancer	5.61e-05	0.000814	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—esophageal cancer	5.61e-05	0.000814	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	5.58e-05	0.000809	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—esophageal cancer	5.55e-05	0.000805	CcSEcCtD
Cyclosporine—ABCB1—lymph node—esophageal cancer	5.53e-05	0.00126	CbGeAlD
Cyclosporine—Confusional state—Methotrexate—esophageal cancer	5.43e-05	0.000787	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—esophageal cancer	5.38e-05	0.000781	CcSEcCtD
Cyclosporine—Infection—Methotrexate—esophageal cancer	5.35e-05	0.000776	CcSEcCtD
Cyclosporine—Hypersensitivity—Capecitabine—esophageal cancer	5.33e-05	0.000773	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—esophageal cancer	5.28e-05	0.000766	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—esophageal cancer	5.27e-05	0.000764	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—esophageal cancer	5.23e-05	0.000758	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—esophageal cancer	5.2e-05	0.000755	CcSEcCtD
Cyclosporine—Asthenia—Capecitabine—esophageal cancer	5.19e-05	0.000752	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—esophageal cancer	5.13e-05	0.000744	CcSEcCtD
Cyclosporine—Pruritus—Capecitabine—esophageal cancer	5.11e-05	0.000742	CcSEcCtD
Cyclosporine—Diarrhoea—Capecitabine—esophageal cancer	4.95e-05	0.000717	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	4.9e-05	0.000711	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—esophageal cancer	4.87e-05	0.000706	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—esophageal cancer	4.83e-05	0.000701	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—esophageal cancer	4.8e-05	0.000696	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—esophageal cancer	4.78e-05	0.000694	CcSEcCtD
Cyclosporine—Dizziness—Capecitabine—esophageal cancer	4.78e-05	0.000693	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—esophageal cancer	4.74e-05	0.000687	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—esophageal cancer	4.68e-05	0.000679	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—esophageal cancer	4.65e-05	0.000674	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—esophageal cancer	4.64e-05	0.000673	CcSEcCtD
Cyclosporine—Pain—Methotrexate—esophageal cancer	4.6e-05	0.000668	CcSEcCtD
Cyclosporine—Vomiting—Capecitabine—esophageal cancer	4.6e-05	0.000667	CcSEcCtD
Cyclosporine—Rash—Capecitabine—esophageal cancer	4.56e-05	0.000661	CcSEcCtD
Cyclosporine—Dermatitis—Capecitabine—esophageal cancer	4.55e-05	0.000661	CcSEcCtD
Cyclosporine—Headache—Capecitabine—esophageal cancer	4.53e-05	0.000657	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—esophageal cancer	4.43e-05	0.000643	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—esophageal cancer	4.4e-05	0.000638	CcSEcCtD
Cyclosporine—Nausea—Capecitabine—esophageal cancer	4.29e-05	0.000623	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—esophageal cancer	4.28e-05	0.00062	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—esophageal cancer	4.25e-05	0.000617	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—esophageal cancer	4.25e-05	0.000617	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—esophageal cancer	3.97e-05	0.000575	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—esophageal cancer	3.86e-05	0.00056	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—esophageal cancer	3.81e-05	0.000552	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—esophageal cancer	3.68e-05	0.000534	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—esophageal cancer	3.56e-05	0.000516	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—esophageal cancer	3.42e-05	0.000496	CcSEcCtD
Cyclosporine—Rash—Methotrexate—esophageal cancer	3.39e-05	0.000492	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—esophageal cancer	3.39e-05	0.000492	CcSEcCtD
Cyclosporine—Headache—Methotrexate—esophageal cancer	3.37e-05	0.000489	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—esophageal cancer	3.2e-05	0.000464	CcSEcCtD
Cyclosporine—CYP2C8—Metabolism—GAPDH—esophageal cancer	3.81e-06	4.26e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—HMOX1—esophageal cancer	3.81e-06	4.26e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NOS3—esophageal cancer	3.78e-06	4.23e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CRABP1—esophageal cancer	3.77e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALOX15—esophageal cancer	3.77e-06	4.21e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HIF1A—esophageal cancer	3.75e-06	4.2e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TYMP—esophageal cancer	3.74e-06	4.19e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.73e-06	4.18e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TYMP—esophageal cancer	3.71e-06	4.15e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.71e-06	4.15e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EP300—esophageal cancer	3.71e-06	4.15e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTT1—esophageal cancer	3.69e-06	4.13e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTO1—esophageal cancer	3.68e-06	4.12e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TPI1—esophageal cancer	3.68e-06	4.12e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ABCB1—esophageal cancer	3.65e-06	4.09e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	3.65e-06	4.08e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.64e-06	4.08e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	3.61e-06	4.04e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTO1—esophageal cancer	3.59e-06	4.02e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TPI1—esophageal cancer	3.59e-06	4.02e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GNG7—esophageal cancer	3.59e-06	4.01e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—esophageal cancer	3.58e-06	4e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.55e-06	3.97e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ERBB2—esophageal cancer	3.53e-06	3.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALDOB—esophageal cancer	3.53e-06	3.95e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—HMOX1—esophageal cancer	3.52e-06	3.94e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALOX15—esophageal cancer	3.52e-06	3.94e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EGFR—esophageal cancer	3.5e-06	3.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—HMOX1—esophageal cancer	3.49e-06	3.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS1—esophageal cancer	3.46e-06	3.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ENO1—esophageal cancer	3.46e-06	3.87e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALDOB—esophageal cancer	3.45e-06	3.85e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.44e-06	3.84e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CA1—esophageal cancer	3.44e-06	3.84e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—CREBBP—esophageal cancer	3.42e-06	3.83e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NOS2—esophageal cancer	3.42e-06	3.82e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PSME1—esophageal cancer	3.41e-06	3.81e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PSME2—esophageal cancer	3.41e-06	3.81e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GAPDH—esophageal cancer	3.4e-06	3.8e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.39e-06	3.79e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TPI1—esophageal cancer	3.39e-06	3.79e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NOTCH1—esophageal cancer	3.38e-06	3.78e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ABCB1—esophageal cancer	3.38e-06	3.78e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CRABP1—esophageal cancer	3.37e-06	3.77e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ALDH2—esophageal cancer	3.36e-06	3.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TPI1—esophageal cancer	3.36e-06	3.76e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTO1—esophageal cancer	3.36e-06	3.76e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ABCB1—esophageal cancer	3.35e-06	3.75e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GAPDH—esophageal cancer	3.32e-06	3.71e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.31e-06	3.7e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CRABP1—esophageal cancer	3.29e-06	3.68e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—CREBBP—esophageal cancer	3.28e-06	3.67e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.25e-06	3.63e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—esophageal cancer	3.23e-06	3.61e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.23e-06	3.61e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALDOB—esophageal cancer	3.22e-06	3.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GNG7—esophageal cancer	3.2e-06	3.58e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.2e-06	3.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTT1—esophageal cancer	3.2e-06	3.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	3.16e-06	3.54e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—esophageal cancer	3.16e-06	3.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.15e-06	3.52e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CA2—esophageal cancer	3.14e-06	3.52e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GNG7—esophageal cancer	3.13e-06	3.5e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.13e-06	3.5e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCND1—esophageal cancer	3.12e-06	3.49e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GAPDH—esophageal cancer	3.1e-06	3.47e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.1e-06	3.47e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CRABP1—esophageal cancer	3.07e-06	3.44e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CREBBP—esophageal cancer	3.07e-06	3.43e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—NOS3—esophageal cancer	3.06e-06	3.42e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PIK3CA—esophageal cancer	3.04e-06	3.4e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CDKN1A—esophageal cancer	3.02e-06	3.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALDH2—esophageal cancer	3e-06	3.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ENO1—esophageal cancer	3e-06	3.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS1—esophageal cancer	3e-06	3.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PSME2—esophageal cancer	2.95e-06	3.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PSME1—esophageal cancer	2.95e-06	3.3e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GNG7—esophageal cancer	2.95e-06	3.3e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.94e-06	3.29e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—NOS3—esophageal cancer	2.94e-06	3.28e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALDH2—esophageal cancer	2.93e-06	3.28e-05	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PIK3CA—esophageal cancer	2.92e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ADH7—esophageal cancer	2.92e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.92e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GNG7—esophageal cancer	2.92e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.91e-06	3.25e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EP300—esophageal cancer	2.87e-06	3.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.86e-06	3.19e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—CREBBP—esophageal cancer	2.85e-06	3.19e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.82e-06	3.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.81e-06	3.14e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—esophageal cancer	2.8e-06	3.13e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTT1—esophageal cancer	2.79e-06	3.12e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.77e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.76e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.76e-06	3.09e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.75e-06	3.08e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NOS3—esophageal cancer	2.75e-06	3.07e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PIK3CA—esophageal cancer	2.74e-06	3.07e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.74e-06	3.06e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—esophageal cancer	2.68e-06	3e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ENO1—esophageal cancer	2.68e-06	2.99e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.68e-06	2.99e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—esophageal cancer	2.65e-06	2.97e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PSME1—esophageal cancer	2.64e-06	2.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PSME2—esophageal cancer	2.64e-06	2.95e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.63e-06	2.94e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ENO1—esophageal cancer	2.61e-06	2.92e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS1—esophageal cancer	2.61e-06	2.92e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.61e-06	2.92e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.6e-06	2.91e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.6e-06	2.9e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.58e-06	2.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.57e-06	2.88e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PSME2—esophageal cancer	2.57e-06	2.88e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PSME1—esophageal cancer	2.57e-06	2.88e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CREBBP—esophageal cancer	2.57e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—esophageal cancer	2.57e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.56e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.56e-06	2.87e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—NOS3—esophageal cancer	2.56e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.55e-06	2.85e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.52e-06	2.82e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—esophageal cancer	2.51e-06	2.81e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—esophageal cancer	2.5e-06	2.8e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ENO1—esophageal cancer	2.46e-06	2.75e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.46e-06	2.75e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—esophageal cancer	2.45e-06	2.74e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMP—esophageal cancer	2.45e-06	2.74e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CREBBP—esophageal cancer	2.44e-06	2.73e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.44e-06	2.73e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ENO1—esophageal cancer	2.44e-06	2.73e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PSME1—esophageal cancer	2.42e-06	2.71e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PSME2—esophageal cancer	2.42e-06	2.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.42e-06	2.71e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PSME2—esophageal cancer	2.4e-06	2.69e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PSME1—esophageal cancer	2.4e-06	2.69e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	2.4e-06	2.68e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.38e-06	2.66e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—esophageal cancer	2.34e-06	2.61e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—EP300—esophageal cancer	2.33e-06	2.61e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.32e-06	2.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.3e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—NOS3—esophageal cancer	2.3e-06	2.57e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.27e-06	2.54e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CREBBP—esophageal cancer	2.26e-06	2.53e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.24e-06	2.51e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—EP300—esophageal cancer	2.23e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.22e-06	2.48e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.21e-06	2.48e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.21e-06	2.48e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1A—esophageal cancer	2.2e-06	2.46e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—HMOX1—esophageal cancer	2.19e-06	2.45e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—NOS3—esophageal cancer	2.19e-06	2.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.15e-06	2.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.14e-06	2.39e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PIK3CA—esophageal cancer	2.13e-06	2.38e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.12e-06	2.37e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—esophageal cancer	2.1e-06	2.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.1e-06	2.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ABCB1—esophageal cancer	2.1e-06	2.35e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.09e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EP300—esophageal cancer	2.09e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.09e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.07e-06	2.32e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—esophageal cancer	2.06e-06	2.3e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.04e-06	2.29e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.03e-06	2.27e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—NOS3—esophageal cancer	2.02e-06	2.26e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—NOS3—esophageal cancer	2.01e-06	2.24e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—esophageal cancer	2e-06	2.24e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.97e-06	2.2e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.95e-06	2.18e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.95e-06	2.18e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—EP300—esophageal cancer	1.94e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.93e-06	2.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.91e-06	2.14e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.9e-06	2.13e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.87e-06	2.1e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—esophageal cancer	1.85e-06	2.07e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—esophageal cancer	1.83e-06	2.05e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—esophageal cancer	1.82e-06	2.04e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.8e-06	2.02e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.8e-06	2.01e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—esophageal cancer	1.78e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.78e-06	1.99e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—EP300—esophageal cancer	1.75e-06	1.96e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.75e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.72e-06	1.93e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PIK3CA—esophageal cancer	1.72e-06	1.93e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.72e-06	1.92e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.71e-06	1.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.7e-06	1.9e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—EP300—esophageal cancer	1.66e-06	1.86e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PIK3CA—esophageal cancer	1.65e-06	1.85e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.62e-06	1.81e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.61e-06	1.8e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.61e-06	1.8e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.59e-06	1.78e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PSME2—esophageal cancer	1.59e-06	1.77e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PSME1—esophageal cancer	1.59e-06	1.77e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PIK3CA—esophageal cancer	1.55e-06	1.73e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—EP300—esophageal cancer	1.54e-06	1.72e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—EP300—esophageal cancer	1.53e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NOS3—esophageal cancer	1.45e-06	1.62e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	1.44e-06	1.61e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.42e-06	1.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.4e-06	1.57e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.37e-06	1.53e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.33e-06	1.48e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PIK3CA—esophageal cancer	1.29e-06	1.45e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.29e-06	1.44e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.29e-06	1.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NOS3—esophageal cancer	1.26e-06	1.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.25e-06	1.4e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	1.23e-06	1.38e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.22e-06	1.37e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.17e-06	1.31e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.15e-06	1.29e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.15e-06	1.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.14e-06	1.28e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.14e-06	1.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.13e-06	1.26e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.13e-06	1.26e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NOS3—esophageal cancer	1.12e-06	1.25e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—EP300—esophageal cancer	1.1e-06	1.23e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NOS3—esophageal cancer	1.09e-06	1.22e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.03e-06	1.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.03e-06	1.15e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NOS3—esophageal cancer	1.02e-06	1.14e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—esophageal cancer	1e-06	1.12e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—EP300—esophageal cancer	9.55e-07	1.07e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—esophageal cancer	9.43e-07	1.05e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—esophageal cancer	9.35e-07	1.05e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—EP300—esophageal cancer	8.53e-07	9.54e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—EP300—esophageal cancer	8.32e-07	9.31e-06	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	8.16e-07	9.13e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—EP300—esophageal cancer	7.84e-07	8.77e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—EP300—esophageal cancer	7.77e-07	8.7e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CREBBP—esophageal cancer	7.53e-07	8.42e-06	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	7.07e-07	7.91e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NOS3—esophageal cancer	6.74e-07	7.54e-06	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	6.31e-07	7.06e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—esophageal cancer	6.17e-07	6.9e-06	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PIK3CA—esophageal cancer	6.16e-07	6.89e-06	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	5.8e-07	6.49e-06	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	5.75e-07	6.43e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—EP300—esophageal cancer	5.13e-07	5.74e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.79e-07	4.24e-06	CbGpPWpGaD
